Hostname: page-component-7b7567c8c-tnzcf Total loading time: 0 Render date: 2026-11-13T09:36:43.830Z Has data issue: false hasContentIssue false
  • English
  • Français

Reduced total complement haemolytic activity in schizophrenic patients

Published online by Cambridge University Press:  09 July 2009

Baruch Spivak,
Marguerite Radwan,
Jonathan Brandon,
Yehuda Baruch,
Mike Stawski,
Sam Tyano and
Abraham Weizman
Baruch Spivak*
Affiliation:
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Israel
Marguerite Radwan
Affiliation:
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Israel
Jonathan Brandon
Affiliation:
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Israel
Yehuda Baruch
Affiliation:
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Israel
Mike Stawski
Affiliation:
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Israel
Sam Tyano
Affiliation:
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Israel
Abraham Weizman
Affiliation:
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Israel
*
1Address for correspondence: Dr B. Spivak, Geha Psychiatric Hospital, Beilinson Medical Center, PO Box 102, Petah Tiqva 49100, Israel.
Get accessRights & Permissions [Opens in a new window]

Synopsis

Serum concentrations of the third and fourth components of the complement system and total complement haemolytic activity were measured in 167 psychiatric patients. Total complement haemolytic activity was decreased in chronic schizophrenic patients as compared to healthy controls and bipolar patients. The relatively diminished total haemolytic activity was not attributable to drug treatment. It is not clear if the reduced total haemolytic activity is an epiphenomenon or related to the involvement of an autoimmune process in the pathophysiology of schizophrenia.

Information

Type
Original Articles
Information
Psychological Medicine , Volume 23 , Issue 2 , May 1993, pp. 315 - 318
Copyright
Copyright © Cambridge University Press 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Barrett, J. T. (1988). Textbook in Immunology, (5th edn), pp. 165–187. CV Mosby Company: St Louis.Google Scholar
Calabrese, J. R., Kling, M. A. & Gold, P. W. (1987). Alteration in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulation. American Journal of Psychiatry 144, 1123–1134.Google ScholarPubMed
Fearon, D. T. & Austen, K. F. (1980). The alternative pathway of complement – a system for host resistance to microbial infection. New England Journal of Medicine 303, 259–263.CrossRefGoogle ScholarPubMed
Hudson, L. & Hay, F. C. (1989). Practical Immunology, (3rd edn), pp. 264–280. Blackwell Scientific Publication: Oxford.Google Scholar
Hunsicker, M. C., Ruddy, S., Carpenter, C. B., Schur, P. H., Merrill, J. P., Müller-Eberhard, H. J. & Austen, K. F. (1972). Metabolism of third complement component (C3) in nephritis. New England Journal of Medicine 287, 835–840.CrossRefGoogle ScholarPubMed
Knight, J., Knight, A. & Ungvari, G. (1992). Can autoimmune mechanisms account for the genetic predisposition to schizophrenia? British Journal of Psychiatry 160, 533–540.CrossRefGoogle ScholarPubMed
O'Riordan, J. W., Kelleker, D., Williams, Y. & Bloomfield, F. J. (1986). Effect of lithium therapy on inflammatory response. Inflammation 10, 49–57.CrossRefGoogle Scholar
Porter, R. R. & Reid, K. B. M. (1978). The biochemistry of complement. Nature 275, 699–704.CrossRefGoogle ScholarPubMed
Schur, P. H. & Austen, K. F. (1968). Complement in human disease. Annual Review of Medicine 19, 1–24.CrossRefGoogle ScholarPubMed
Spivak, B., Radwan, M., Elimelech, D., Baruch, Y., Avidan, G. & Tyano, S. (1989). A study of the complement system in psychiatric patients. Biological Psychiatry 26, 640–642.CrossRefGoogle ScholarPubMed
Zarrabi, M. H., Zucker, S., Miller, F., Denman, R. M., Romano, G. S., Hartnett, G. A. & Varma, A. O. (1979). Immunologic and coagulation disorders in chlorpromazine-treated patients. Annals of Internal Medicine 91, 194–199.CrossRefGoogle ScholarPubMed